These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 12592062)

  • 1. Body composition modulates the effects of hormone replacement therapy on growth hormone and insulin-like growth factor-I levels in postmenopausal women.
    Figueroa A; Going SB; Milliken LA; Blew R; Sharp S; Lohman TG
    Gynecol Obstet Invest; 2002; 54(4):201-6. PubMed ID: 12592062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin in postmenopausal women: influence of hormone therapy, insulin, and fat distribution.
    Gower BA; Nagy TR; Goran MI; Smith A; Kent E
    J Clin Endocrinol Metab; 2000 May; 85(5):1770-5. PubMed ID: 10843150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal determinants of regional body composition in adolescent girls with anorexia nervosa and controls.
    Misra M; Miller KK; Almazan C; Worley M; Herzog DB; Klibanski A
    J Clin Endocrinol Metab; 2005 May; 90(5):2580-7. PubMed ID: 15713709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between hormone replacement therapy use with body fat distribution and insulin sensitivity in obese postmenopausal women.
    Sites CK; Brochu M; Tchernof A; Poehlman ET
    Metabolism; 2001 Jul; 50(7):835-40. PubMed ID: 11436191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of exercise training and hormone replacement therapy on lean and fat mass in postmenopausal women.
    Figueroa A; Going SB; Milliken LA; Blew RM; Sharp S; Teixeira PJ; Lohman TG
    J Gerontol A Biol Sci Med Sci; 2003 Mar; 58(3):266-70. PubMed ID: 12634293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fat distribution and insulin sensitivity in postmenopausal women: influence of hormone replacement.
    Munoz J; Derstine A; Gower BA
    Obes Res; 2002 Jun; 10(6):424-31. PubMed ID: 12055317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Sex Hormones, IGF-1, and IGFBP3 Exert a Sexually Dimorphic Effect on Lean Body Mass in Aging.
    Waters DL; Yau CL; Montoya GD; Baumgartner RN
    J Gerontol A Biol Sci Med Sci; 2003 Jul; 58(7):648-52. PubMed ID: 12865482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy affects body composition and leptin differently in obese and non-obese postmenopausal women.
    Kristensen K; Pedersen SB; Vestergaard P; Mosekilde L; Richelsen B
    J Endocrinol; 1999 Oct; 163(1):55-62. PubMed ID: 10495407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependent changes in body composition in postmenopausal Japanese women: relationship to growth hormone secretion as well as serum levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.
    Sugimoto T; Nakaoka D; Nasu M; Kanzawa M; Sugishita T; Chihara K
    Eur J Endocrinol; 1998 Jun; 138(6):633-9. PubMed ID: 9678529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women.
    Ryan AS; Nicklas BJ; Berman DM
    Diabetes Care; 2002 Jan; 25(1):127-33. PubMed ID: 11772913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interrelationships of spontaneous growth hormone axis activity, body fat, and serum lipids in healthy elderly women and men.
    O'Connor KG; Harman SM; Stevens TE; Jayme JJ; Bellantoni MF; Busby-Whitehead MJ; Christmas C; Münzer T; Tobin JD; Roy TA; Cottrell E; St Clair C; Pabst KM; Blackman MR
    Metabolism; 1999 Nov; 48(11):1424-31. PubMed ID: 10582552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serum levels of growth hormone and insulin-like growth factor-I associated with simultaneous decrease of circulating insulin in postmenopausal women receiving hormone replacement therapy.
    Fonseca E; Ochoa R; Galván R; Hernández M; Mercado M; Zárate A
    Menopause; 1999; 6(1):56-60. PubMed ID: 10100181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity.
    Gleeson HK; Lissett CA; Shalet SM
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1061-7. PubMed ID: 15522943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary data on the relationship between circulating levels of Sirtuin 4, anthropometric and metabolic parameters in obese subjects according to growth hormone/insulin-like growth factor-1 status.
    Savastano S; Di Somma C; Colao A; Barrea L; Orio F; Finelli C; Pasanisi F; Contaldo F; Tarantino G
    Growth Horm IGF Res; 2015 Feb; 25(1):28-33. PubMed ID: 25466907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relations between body composition, functional and hormonal parameters and quality of life in healthy postmenopausal women.
    Lebrun CE; van der Schouw YT; de Jong FH; Pols HA; Grobbee DE; Lamberts SW
    Maturitas; 2006 Aug; 55(1):82-92. PubMed ID: 16497451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition.
    De Marinis L; Bianchi A; Mancini A; Gentilella R; Perrelli M; Giampietro A; Porcelli T; Tilaro L; Fusco A; Valle D; Tacchino RM
    J Clin Endocrinol Metab; 2004 Jan; 89(1):174-80. PubMed ID: 14715846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women.
    O'Sullivan AJ; Crampton LJ; Freund J; Ho KK
    J Clin Invest; 1998 Sep; 102(5):1035-40. PubMed ID: 9727072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.
    Svensson J; Lönn L; Jansson JO; Murphy G; Wyss D; Krupa D; Cerchio K; Polvino W; Gertz B; Boseaus I; Sjöström L; Bengtsson BA
    J Clin Endocrinol Metab; 1998 Feb; 83(2):362-9. PubMed ID: 9467542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of replacement estrogen on insulin-like growth factor-I in postmenopausal women: the Rancho Bernardo Study.
    Goodman-Gruen D; Barrett-Connor E
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4268-71. PubMed ID: 8954026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of C-reactive protein are associated with obesity, weight gain, and hormone replacement therapy in healthy postmenopausal women.
    Barinas-Mitchell E; Cushman M; Meilahn EN; Tracy RP; Kuller LH
    Am J Epidemiol; 2001 Jun; 153(11):1094-101. PubMed ID: 11390329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.